9 Best GLP-1 Providers in 2026

We scored nine telehealth providers across five weighted criteria. The weights are published here so you can disagree with them and reweight for yourself.

The heaviest criterion is what’s included in the base price, and that’s the one we win. We weighted it first because in a category where the advertised number routinely excludes half of what you need, total value tells you more than a headline figure. It’s also, plainly, the decision that puts us at the top.

Weight it differently and the order changes. Put lowest headline price at 50% and Henry Meds or Found comes first. That’s a perfectly sensible way to buy this, and the pricing section gives you what you need to make that call.

What we deliberately avoided was scoring anything soft. There’s no “quality of coaching” rating here, because we couldn’t measure that on a competitor without making it up. What’s included versus what costs extra is a list anyone can check.

All pricing reflects the lowest publicly advertised rate as of September 2026, with the commitment length required to obtain it noted in each review.

Nine providers, compared on the criteria above. Starting prices assume the longest commitment each provider offers, which is how these companies advertise. Month-to-month costs are covered in the pricing section.

Pricing compiled September 2026 from published third-party trackers. This category reprices frequently — confirm current rates directly with any provider before signing up. Brand-name Wegovy lists at approximately $1,349/month and Zepbound at $1,271/month without coverage.

Each provider below is assigned the category it genuinely wins. Every entry includes at least one real drawback — a provider with no downsides is an advertisement, not a review.

From $179/month · Personalised GLP-1 medication · Supplement kit worth up to $1,449, included · Private Care Coach, included

Meant is built around a premise the rest of this category mostly ignores: the medication is the easy part, and what happens after you stop is the part that decides whether any of it worked.

Most GLP-1 telehealth is transactional. You complete an intake form, a clinician approves a prescription, a pharmacy ships a monthly refill, and you message someone if side effects get bad. That model works if all you need is access to the drug. It does considerably less for the eighteen months after.

Meant bundles three things into one monthly price, and they map directly onto the criterion this list is ranked by.

1 · Personalised GLP-1 medication. Formulated to your prescribed dose, prescribed by board-certified clinicians, and prepared by licensed US pharmacies. Clinical services are provided by OpenLoop Health, a separate licensed telehealth provider, and Meant is LegitScript certified — the same certification Google and Meta require before a telehealth business can advertise prescription treatment at all.

2 · The full supplement kit. A curated kit covering hair, sleep, gut, energy and recovery — the areas most affected during rapid weight loss, when appetite drops sharply and total food intake falls with it. Valued at up to $1,449 and included at no additional cost.

3 · A private Care Coach. Real one-to-one coaching from a certified coach who knows your plan and your goals. Not a chatbot, not a shared inbox, not a clinician you message only when something goes wrong. Included at no additional cost.

Medication reduces hunger. The supplements support your body through the change. The coaching is what makes it stick.

Why the third one matters most. The STEP-4 trial found that participants who stopped semaglutide regained most of their lost weight within a year. Medication alone is a temporary intervention with a permanent price tag. The behaviour change is what converts it into a durable result — and it is precisely the part almost nobody in this category is selling.

Pros

• Three components — medication, supplement kit and one-to-one coaching — in a single monthly price
• Supplement kit valued at up to $1,449, included rather than sold as an add-on
• Dedicated, named Care Coach, not clinician messaging alone
• LegitScript certified; clinical services delivered through a licensed partner

Cons

• At $179/month, Meant is not the cheapest option here. Several providers on this list start lower. If your only constraint is price, one of those will serve you better.
• We do not bill insurance. Meant is cash-pay. If you have coverage that includes weight-management medication, LifeMD or Mochi will likely cost you less out of pocket than we will.

Best for: people who have tried losing weight before, regained it, and want the support structure to make this attempt the one that holds.

See what’s included with Meant Health

$178/month all-in · $79 membership + $99 medication · $39 intro membership first month

Mochi splits its pricing into a membership fee and a medication charge, which lands at $178 per month once both are counted. The $99 medication figure is the one that appears in most comparison tables, and it is not what you pay.

To Mochi’s credit, both numbers are published. Plenty of providers in this category do not itemise at all, and a first-month membership of $39 makes trying the service cheap. Mochi is also reported as one of the stronger options for insurance support on branded Wegovy and Zepbound, which matters if you have coverage and want the FDA-approved product rather than a compounded copy.

Pros

• Both fee components published upfront
• $39 first-month membership lowers the trial cost
• Insurance support for brand-name medication

Cons

• The advertised $99 is medication only — real cost is $178
• The membership fee continues whether or not you are receiving medication that month

From $159/month · Video consultations · Medication-focused

Found’s distinguishing feature is that it does not treat GLP-1s as the only answer. It prescribes metformin, bupropion/naltrexone combinations and other weight-management medications alongside them, which makes it a genuine option for people who do not qualify for a GLP-1, cannot tolerate the side effects, or are looking for something less expensive.

That flexibility has real clinical value. Roughly a fifth of people discontinue GLP-1 treatment due to gastrointestinal side effects, and at most providers that means the programme ends. At Found there is somewhere to go next.

Video consultations are available, which not every provider on this list offers.

Pros

• Prescribes beyond GLP-1s — a genuine path if you don’t tolerate or qualify
• Video consultations, not async-only
• Mid-range pricing with app-based support content

Cons

• Price covers medication and clinical access only — no coaching programme or supplements
• Broader formulary means less specialisation in GLP-1 protocols specifically

$149/month semaglutide · $349/month tirzepatide · Fast fulfilment

If your only criterion is the lowest number on a compounded semaglutide plan, Henry Meds is among the cheapest credible options, and it is known for quick sign-up and shipping.

Two things to understand before choosing on price. First, the jump from semaglutide to tirzepatide is steep — $149 to $349 — so if you or your clinician later prefer tirzepatide, your cost more than doubles. Second, labs are not included. Providers at this price point generally do not include bloodwork, and if your clinician wants it you pay separately.

This is a medication-access service. There is no coaching, no structured programme, and no supplement support.

Pros

• Among the lowest published prices for compounded semaglutide
• Fast intake and shipping
• Simple, single-line pricing with no membership component

Cons

• Tirzepatide costs more than double the semaglutide plan
• No labs, no coaching, no programme — medication access only

$150–350/month compounded · $500–1,500/month brand-name · NASDAQ: LFMD

LifeMD is one of the few providers with a clear route to brand-name Wegovy or Zepbound, which matters more in 2026 than it did a year ago as compounded supply contracts. It is also publicly traded, which means financial reporting obligations that private telehealth startups do not carry — a modest transparency advantage.

The pricing is the problem. LifeMD’s model varies by medication, formulation and plan tier, and the consultation is billed separately from the medication. That makes direct comparison genuinely difficult, and it is the reason the range above is so wide. Without insurance, the brand-name route runs among the highest annual costs in the market.

Video consultations are available.

Pros

• Genuine brand-name path to Wegovy and Zepbound
• Publicly traded, with the reporting obligations that brings
• Video consultations available

Cons

• Pricing varies so widely by tier that you cannot know your cost before starting intake
• Consultation fee is charged separately from medication

$149/month reported · Async-only consultations · No labs included

Ro is one of the largest telehealth companies in the US, with millions of patients across its service lines. Scale brings real advantages here: mature fulfilment, established pharmacy relationships, and a support operation that has handled volume.

Two caveats. Consultations are asynchronous only — you complete a questionnaire and a clinician reviews it, with no video appointment. For a straightforward case that is efficient. If your history is complicated, it is less reassuring than a conversation.

More importantly, Ro’s compounded GLP-1 availability is uncertain as of late 2026. At least one industry tracker reported Ro exiting the compounded category during 2026, following Hims. Confirm what Ro is currently able to supply before enrolling.

Pros

• Among the largest and most operationally established providers
• Simple single-line pricing
• Mature fulfilment and support infrastructure

Cons

• Async-only — no video consultation with a clinician
• Compounded availability uncertain; confirm current offering directly

$149/month · Brand-name medication only since 2026 · NYSE-listed · Async-only

Hims fully exited compounded GLP-1s during 2026 and now sells only FDA-approved branded medication. Depending on your priorities that is either the main drawback or the main attraction.

It removes a category of risk entirely. FDA-approved products have been through review for safety, efficacy and manufacturing quality, and they are not exposed to the enforcement pressure currently reshaping the compounding market. If regulatory uncertainty is what worries you, Hims has already resolved it.

The trade-off is that weight loss is one product line among many at Hims, and the clinical model reflects that generalism. Consultations are asynchronous.

Pros

• FDA-approved medication only — no compounding regulatory exposure
• Established NYSE-listed company with mature operations
• Integrates with other Hims services if you already use them

Cons

• Async-only consultations, no video
• Weight management is one line among many rather than a specialism

Pricing not published upfront · 12-month commitment required · Includes labs

Calibrate sits at the premium end and operates a year-long structured programme rather than a monthly medication subscription. It includes bloodwork, which most budget providers do not, and offers video consultations.

The 12-month commitment is the thing to weigh. It is a real cost that does not appear in any headline figure, and it transfers the risk to you: if the medication does not suit you at month three, you are still committed. Calibrate also does not publish pricing before you begin intake, which makes it impossible to compare against the rest of this list without contacting them.

For someone who wants a structured year and is confident in the commitment, the programme depth is genuine.

Pros

• Includes lab work, which budget providers do not
• Video consultations with clinicians
• Structured year-long programme rather than refill-only service

Cons

• 12-month commitment is a substantial hidden cost
• Pricing not published — you cannot compare before starting intake

Zepbound $299/month · Direct from Eli Lilly · No clinical programme

LillyDirect is not a telehealth programme and we have included it anyway, because it is the cheapest legitimate route to brand-name tirzepatide and readers comparing costs deserve to know it exists.

Eli Lilly sells Zepbound direct to patients at $299 per month for self-pay. That is FDA-approved medication from the manufacturer, at a price below several compounded telehealth plans on this list — a comparison that would have been impossible a year ago and is a direct consequence of the compounding market contracting.

What you do not get is any of the wrapper. No coaching, no programme, no nutritional guidance, no ongoing support beyond the prescription itself.

Pros

• Cheapest published route to brand-name tirzepatide
• FDA-approved medication direct from the manufacturer
• No compounding regulatory exposure

Cons

• Medication only — no coaching, programme or clinical support
• Tirzepatide only; no semaglutide option through this channel

Pricing is where most people get caught out, because the advertised number and the number you actually pay are frequently different.

The monthly figure a provider advertises typically assumes the longest commitment available — usually 12 months, paid upfront or billed monthly with a cancellation penalty. Month-to-month pricing commonly runs 40–80% higher. Read which number you are being quoted before you enter card details.

Also commonly excluded:

• Initial consultation fee — some providers charge separately, some fold it in
• Lab work, where required
• Dose escalation. This is the big one. GLP-1 dosing steps up over the first months, and several providers price by dose. The month-one price is often not the month-six price.
• Shipping, on some plans

Brand-name Ozempic, Wegovy, Zepbound and Mounjaro carry list prices well above what most cash-pay telehealth charges for compounded alternatives. Where insurance covers a brand-name GLP-1, the out-of-pocket cost can fall below any cash-pay compounded option — which is why providers that actively navigate insurance are worth considering even at a higher subscription fee.

Coverage remains inconsistent. Many plans exclude weight-loss indications entirely while covering the same molecule for type 2 diabetes.

Henry Meds currently advertises among the lowest entry prices at $149 per month for compounded semaglutide. Before choosing on that basis, check three things: whether the price holds at higher doses, what the commitment length is, and whether the consultation and labs are included. Henry’s tirzepatide plan is $349 — more than double.

A provider at $149 per month with dose-based escalation pricing can cost more across a year than one at a flat higher rate.

The more useful comparison is cost per thing included. Several providers on this list price the medication low and sell coaching, programme access or supplements as separate add-ons — or simply do not offer them.

Meant Health at $179/month includes the medication, a private Care Coach and a supplement kit valued at up to $1,449, in a single price with no add-on tier. Henry Meds at $149 and Found at $159 cover medication and clinical access only. Mochi’s $99 medication charge becomes $178 once the required membership is added. Calibrate includes labs and a programme but does not publish its price and requires a full year’s commitment.

Work out what you would pay elsewhere for the same combination before deciding which number is actually lower.

All pricing as of September 2026.

This distinction determines both what you pay and what you are taking, and it is the single most important thing to understand before choosing a provider.

Brand-name GLP-1 medications are FDA-approved. Ozempic and Wegovy (semaglutide, Novo Nordisk) and Mounjaro and Zepbound (tirzepatide, Eli Lilly) have been through FDA review and are manufactured under FDA-regulated conditions. Their efficacy is supported by large randomised trials — STEP-1 for semaglutide and SURMOUNT-1 for tirzepatide, both published in the New England Journal of Medicine.

Compounded semaglutide and tirzepatide are not FDA-approved. Compounded drugs are prepared by pharmacies for individual patients and do not undergo FDA review for safety, efficacy or quality. The FDA has published guidance on compounded GLP-1 medications, and has previously issued warnings about products sold as semaglutide that contained salt forms not equivalent to the approved active ingredient.

Compounded versions cost substantially less, which is why most cash-pay telehealth is built on them.

If you are considering a compounded medication, ask your provider three questions:

1. Which pharmacy compounds it, and is that pharmacy’s state licence verifiable?

2. Is the pharmacy 503A or 503B registered?

3. Is third-party purity and potency testing performed, and can you see the results?

A provider that cannot answer all three in writing is a provider to skip.

If you compared GLP-1 providers even twelve months ago, the landscape has moved and the old advice no longer holds.

Compounded semaglutide and tirzepatide became widely available during the 2022–2025 shortage, when federal rules permitted compounding pharmacies to prepare copies of drugs in short supply. The FDA declared the semaglutide shortage resolved in February 2025, and the compounding windows closed on the deadlines that followed.

Since then the category has contracted sharply. The FDA issued warning letters to more than 30 compounded GLP-1 companies in early 2026. Hims & Hers exited compounding entirely and now sells only FDA-approved branded medication. Other large providers have restricted supply or followed suit. A further FDA proposal affecting 503B outsourcing facilities was published in April 2026.

What this means for you as a buyer:

• A provider advertising cheap compounded medication today may not be able to supply it in six months
• Ask directly whether a provider is currently shipping compounded product, and what happens to your plan if it stops
• Brand-name access matters more than it did a year ago. Eli Lilly now sells Zepbound direct at $299/month through LillyDirect, which is below several compounded telehealth plans
• Prices quoted in articles written before mid-2026 are unreliable

This is the single biggest reason to check a provider’s current medication list rather than trusting a comparison page, including this one.

Eligibility is largely standardised across providers because it follows the FDA-approved indications for the underlying medications.

Typical criteria:

• BMI of 30 or above, or
• BMI of 27 or above with at least one weight-related condition — type 2 diabetes, hypertension, dyslipidaemia, obstructive sleep apnoea or cardiovascular disease

Common exclusions. Most providers will not prescribe a GLP-1 if you have a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, a history of pancreatitis, active gallbladder disease, or if you are pregnant, breastfeeding or planning pregnancy.

What the intake involves. Expect a medical history questionnaire, current medications and allergies, height and weight, and in most cases a synchronous or asynchronous consultation with a licensed clinician. Some providers require recent lab work; others will prescribe without it.

State availability varies. Telehealth prescribing is regulated state by state, and no provider operates everywhere. Confirm your state before paying anything.

A clinician can decline to prescribe. That is the system working, not a defect in the service.

Check your eligibility with Meant Health — the intake takes a few minutes and a licensed clinician reviews every application.

No named pharmacy. If a provider will not tell you which pharmacy fills your prescription, you cannot verify its licensure. Reputable providers name their partners and their state licence numbers.

No licensed clinician consultation. A questionnaire alone is not a clinical assessment. There should be a licensed prescriber involved and you should be able to find out who.

Pricing that only appears after you enter payment details. Any provider unwilling to publish its pricing before checkout is telling you something.

Long prepayment requirements. Twelve-month commitments paid upfront are common in this category and they transfer all the risk to you. Prefer month-to-month where you can, even at a higher monthly rate — and note that this applies to Meant’s discounted plans too.

Claims of guaranteed results. No provider can guarantee weight loss. Anyone promising a specific number is overselling.

“Independent” review sites owned by a provider. If a comparison site ranks one company first and does not disclose ownership, check the footer, the WHOIS record and the privacy policy. This page discloses its ownership at the top for exactly this reason.

If price is your only constraint, take the cheapest option that names its pharmacy and publishes its pricing before checkout. That is a legitimate way to buy this.

If you have lost weight before and regained it, the calculation changes. What separates a temporary result from a lasting one is not the molecule — every provider here prescribes the same two — it is whether anything is in place to build the habits that hold after the prescription ends.

That is what Meant Health is built for: personalised medication, a private Care Coach, and a supplement kit valued at up to $1,449 — bundled at $179 per month with no add-on tiers.

Start with Meant Health

Pricing collected: September 2026 from published pricing pages and independent price trackers. Confirm current rates directly with each provider before enrolling.

Updated quarterly. GLP-1 pricing changes frequently; this page was last verified September 2026.

Meant Health is a telehealth provider offering GLP-1 medication and coaching. Clinical services are provided by OpenLoop Health. This article is not medical advice. Compounded medications are not FDA-approved. Speak to a licensed clinician about whether a GLP-1 medication is appropriate for you.